C79.3
Conditions
Interventions
Group 1: Patients who have undergone (adjuvant or definitive) radiotherapy for brain metastases.
Sponsors
Klinikum der Universität München
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ? Definitive or postoperative percutaneous radiotherapy ? Single or multiple brain metastases ? Single or fractionated radiotherapy ? Re-irradiation
Exclusion criteria
Exclusion criteria: no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is to analyse the extent of the radiation fields (especially the planning target volume (PTV)), compare it between the different patient cases and correlate it with the survival data (e.g. overall survival (OS)). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives include the identification of side effects such as the frequency of cerebral oedema and radionecrosis and comparison with the dose distribution. For this purpose, the irradiation exposure of the organs at risk (e.g. brain, brain stem, optic nerves) and the quality control with the corresponding constraints are to be analysed. In addition, an analysis of the different irradiation techniques (e.g. 3D plan, VMAT) will be carried out and, in particular, the side effect profiles and the failure rate will be analysed. | — |
Countries
Germany
Contacts
Public ContactSebastian Maier
Klinikum der Universität München
Outcome results
None listed